The host immune response to Clostridium difficileKELLY, Ciarán P; KYNE, Lorraine.Journal of medical microbiology. 2011, Vol 60, Num 8, pp 1070-1079, issn 0022-2615, 10 p.Conference Paper

A 76-Year-Old Man With Recurrent Clostridium difficile-Associated Diarrhea : Review of C difficile InfectionKELLY, Ciaran P.JAMA, the journal of the American Medical Association. 2009, Vol 301, Num 9, pp 954-962, issn 0098-7484, 9 p.Article

Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrheaKYNE, Lorraine; SOUGIOULTZIS, Stavros; MCFARLAND, Lynne V et al.Infection control and hospital epidemiology. 2002, Vol 23, Num 11, pp 653-659, issn 0899-823X, 7 p.Article

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficileKYNE, Lorraine; HAMEL, Mary Beth; POLAVARAM, Rajashekhar et al.Clinical infectious diseases. 2002, Vol 34, Num 3, pp 346-353, issn 1058-4838Article

Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responses : Clostridium difficileSOLOMON, Katie; MARTIN, Alan J; O'DONOGHUE, Caoilfhionn et al.Journal of medical microbiology. 2013, Vol 62, Num 9, pp 1453-1460, issn 0022-2615, 8 p.Conference Paper

Fidaxomicin Inhibits Clostridium difficile Toxin A-Mediated Enteritis in the Mouse IleumHON WAI KOON; SAMANTHA HO; HING, Tressia C et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4642-4650, issn 0066-4804, 9 p.Article

Meta-Analysis of the Placebo Response in Ulcerative ColitisGARUD, Sagar; BROWN, Alphonso; CHEIFETZ, Adam et al.Digestive diseases and sciences. 2008, Vol 53, Num 4, pp 875-891, issn 0163-2116, 17 p.Article

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. CommentaryWILCOX, Mark; MINTON, Jane; KYNE, Lorraine et al.Lancet (British edition). 2001, Vol 357, Num 9251, pp 158-159, issn 0140-6736, 7 p.Article

MIP-3α neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in miceKATCHAR, Kianoosh; KELLY, Ciaran P; KEATES, Sarah et al.American journal of physiology. Gastrointestinal and liver physiology. 2007, Vol 55, Num 5, issn 0193-1857, G1263-G1271Article

The interaction between eating disorders and celiac disease : an exploration of 10 casesLEFFLER, Daniel A; DENNIS, Melinda; GEORGE, Jessica B. Edwards et al.European journal of gastroenterology & hepatology. 2007, Vol 19, Num 3, pp 251-255, issn 0954-691X, 5 p.Article

Clostridium difficile : Specific PathogensKYNE, Lorraine; FARRELL, Richard J; KELLY, Ciaran P et al.Gastroenterology clinics of North America. 2001, Vol 30, Num 3, pp ix-x, issn 0889-8553, 27 p.Article

Human Monoclonal Antibodies against Clostridium difficile Toxins A and B Inhibit Inflammatory and Histologic Responses to the Toxins in Human Colon and Peripheral Blood MonocytesHON WAI KOON; SHIH, David Q; HING, Tressia C et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 7, pp 3214-3223, issn 0066-4804, 10 p.Article

Interruption of Recurrent Clostridium difficile-Associated Diarrhea Episodes by Serial Therapy with Vancomycin and RifaximinJOHNSON, Stuart; SCHRIEVER, Christopher; GALANG, Minerva et al.Clinical infectious diseases. 2007, Vol 44, Num 6, pp 846-848, issn 1058-4838, 3 p.Article

Small Intestinal Release Mesalamine for the Treatment of Refractory Celiac Disease Type IJAMMA, Shailaja; LEFFLER, Daniel A; DENNIS, Melinda et al.Journal of clinical gastroenterology. 2011, Vol 45, Num 1, pp 30-33, issn 0192-0790, 4 p.Article

Human antibody response to surface layer proteins in Clostridium difficile infectionDRUDY, Denise; CALABI, Emanuela; KYNE, Lorraine et al.FEMS immunology and medical microbiology. 2004, Vol 41, Num 3, pp 237-242, issn 0928-8244, 6 p.Article

Navigating the Gluten-free Diet in CollegePANZER, Rebecca M; DENNIS, Melinda; KELLY, Ciaran P et al.Journal of pediatric gastroenterology and nutrition. 2012, Vol 55, Num 6, pp 740-744, issn 0277-2116, 5 p.Article

Topical antisense oligonucleotide therapy against LIX, an enterocyte- expressed CXC chemokine, reduces murine colitisKWON, John H; KEATES, Andrew C; ANTON, Pauline M et al.American journal of physiology. Gastrointestinal and liver physiology. 2005, Vol 52, Num 6, pp G1075-G1083, issn 0193-1857Article

Rifalazil treats and prevents relapse of Clostridium difficile-associated diarrhea in hamstersANTON, Pauline M; O'BRIEN, Michael; KOKKOTOU, Efi et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 10, pp 3975-3979, issn 0066-4804, 5 p.Article

Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in miceKEATES, Andrew C; CASTAGLIUOLO, Ignazio; CRUICKSHANK, William W et al.Gastroenterology (New York, NY. 1943). 2000, Vol 119, Num 4, pp 972-982, issn 0016-5085Article

Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)LEAV, Brett A; BLAIR, Barbra; AMBROSINO, Donna et al.Vaccine. 2010, Vol 28, Num 4, pp 965-969, issn 0264-410X, 5 p.Article

Factors that Influence Adherence to a Gluten-Free Diet in Adults with Celiac DiseaseLEFFLER, Daniel A; EDWARDS-GEORGE, Jessica; DENNIS, Melinda et al.Digestive diseases and sciences. 2008, Vol 53, Num 6, pp 1573-1581, issn 0163-2116, 9 p.Article

Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in miceGHOSE, Chandrabali; KALSY, Anuj; RYAN, Edward T et al.Infection and immunity. 2007, Vol 75, Num 6, pp 2826-2832, issn 0019-9567, 7 p.Article

Safety and efficacy of E. coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pyloriSOUGIOULTZIS, Stavros; LEE, Cynthia K; MICHETTI, Pierre et al.Vaccine. 2002, Vol 21, Num 3-4, pp 194-201, issn 0264-410X, 8 p.Article

The Incidence and Clinical Spectrum of Refractory Celiac Disease in a North American Referral CenterROSHAN, Bakht; LEFFLER, Daniel A; KELLY, Ciaran P et al.The American journal of gastroenterology. 2011, Vol 106, Num 5, pp 923-928, issn 0002-9270, 6 p.Article

Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin ATAYLOR, Claribel P; TUMMALA, Sanjeev; MOLRINE, Deborah et al.Vaccine. 2008, Vol 26, Num 27-28, pp 3404-3409, issn 0264-410X, 6 p.Article